Dimension logo

Dimension

North America, New York, United States, New York

Description

Dimension is a first-of-its-kind firm partnering with founders at the interface of technology and life sciences

Investor Profile

Dimension has backed more than 13 startups, with 6 new investments in the last 12 months alone. The firm has led 7 rounds, about 54% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Germany.
  • Strong thematic focus on Biotechnology, Therapeutics, Pharmaceutical.
  • Led 3 rounds in the past year.

Stage Focus

  • Seed (38%)
  • Series B (31%)
  • Series A (15%)
  • Series Unknown (8%)
  • Pre Seed (8%)

Country Focus

  • United States (62%)
  • United Kingdom (15%)
  • Germany (15%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Life Science
  • Data Integration
  • Software Engineering
  • Clinical Trials
  • Health Care
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dimension frequently co-invest with?

Wireframe Ventures
North America, California, United States, Mill Valley
Co-Investments: 2
Possible Ventures
Europe, Bayern, Germany, Munich
Co-Investments: 2
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 2
Caffeinated Capital
North America, California, United States, San Francisco
Co-Investments: 2
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 3
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 2
FPV Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Pioneer Fund
North America, California, United States, San Francisco
Co-Investments: 2
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does Dimension often collaborate with?

AK
North America, California, United States, San Francisco
Shared Deals: 1
NB
North America, New York, United States, New York
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 1
HK
North America, New York, United States, New York
Shared Deals: 1
FE
North America, California, United States, San Francisco
Shared Deals: 2
GT
North America, California, United States, San Francisco
Shared Deals: 2
EG
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Dimension?

NewLimit

South San Francisco, California, United States

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

BiotechnologyClinical TrialsHealth Care
Convertible NoteOct 20, 2025
Amount Raised: $45,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series DSep 10, 2025
Amount Raised: $213,000,000
Fiveonefour

Portland, Oregon, United States

Fiveonefour helps dev teams build data-intensive features, products and solutions without growing headcount or hiring data specialists.

Software
Series ASep 4, 2025
Amount Raised: $17,000,000
Enveda Biosciences

Boulder, Colorado, United States

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

BiotechnologyPharmaceuticalTherapeutics
Series DSep 4, 2025
Amount Raised: $150,000,000
Convoke

South San Francisco, California, United States

Convoke is curating high-quality datasets, automating workflows, and building a software platform.

ConsultingSoftwareSoftware Engineering
SeedAug 19, 2025
Amount Raised: $8,600,000
Chai Discovery

San Francisco, California, United States

Chai Discovery develops AI models for molecular structure prediction in drug discovery.

Artificial Intelligence (AI)Health CareLife Science
Series AAug 6, 2025
Amount Raised: $70,000,000
Verisian

London, England, United Kingdom

Accelerate drug time to market through real study traceability and unparalleled trial integrity

PharmaceuticalSoftware
SeedMay 29, 2025
Amount Raised: $4,300,000
Lamin

Munich, Bayern, Germany

Open data platform for biology.

Artificial Intelligence (AI)BiotechnologyData IntegrationData ManagementData StorageSoftware Engineering
SeedMay 10, 2025
NewLimit

South San Francisco, California, United States

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

BiotechnologyClinical TrialsHealth Care
Series BMay 6, 2025
Amount Raised: $130,000,000
Stately Bio

Chicago, Illinois, United States

Stately Bio is the trade-off between measuring cells and keeping them alive.

Biotechnology
SeedMay 1, 2025
Amount Raised: $12,000,000